Novartis’ reorganization is paying off, CEO Vas Narasimhan told investors at an event Thursday in London.
The company raised its sales guidance through 2028 and …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.